Cannabis's 280E Tax Trap May Finally Break. We've Heard That Before.

The article notes that cannabis investors may soon benefit from an expedited DEA administrative hearing and a new Schedule III pathway. However, it frames the situation as another familiar crossroads where markets have faced similar outcomes before, implying uncertain near-term payoff. No specific financial figures or guidance changes are provided.

Analysis

The article notes that cannabis investors may soon benefit from an expedited DEA administrative hearing and a new Schedule III pathway. However, it frames the situation as another familiar crossroads where markets have faced similar outcomes before, implying uncertain near-term payoff. No specific financial figures or guidance changes are provided.